Back to Search
Start Over
Evaluation of Muscle Mass and Stiffness with Limb Ultrasound in COVID-19 Survivors.
- Source :
-
Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2022 Feb 17; Vol. 13, pp. 801133. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022). - Publication Year :
- 2022
-
Abstract
- Background: acute illnesses, like COVID-19, can act as a catabolic stimulus on muscles. So far, no study has evaluated muscle mass and quality through limb ultrasound in post-COVID-19 patients.<br />Methods: cross sectional observational study, including patients seen one month after hospital discharge for SARS-CoV-2 pneumonia. The patients underwent a multidimensional evaluation. Moreover, we performed dominant medial gastrocnemius ultrasound (US) to characterize their muscle mass and quality.<br />Results: two hundred fifty-nine individuals (median age 67, 59.8% males) were included in the study. COVID-19 survivors with reduced muscle strength had a lower muscle US thickness (1.6 versus 1.73 cm, p =0.02) and a higher muscle stiffness (87 versus 76.3, p = 0.004) compared to patients with normal muscle strength. Also, patients with reduced Short Physical Performance Battery (SPPB) scores had a lower muscle US thickness (1.3 versus 1.71 cm, p = 0.01) and a higher muscle stiffness (104.9 versus 81.07, p = 0.04) compared to individuals with normal SPPB scores. The finding of increased muscle stiffness was also confirmed in patients with a pathological value (≥ 4) at the sarcopenia screening tool SARC-F (103.0 versus 79.55, p < 0.001). Muscle stiffness emerged as a significant predictor of probable sarcopenia (adjusted OR 1.02, 95% C.I. 1.002 - 1.04, p = 0.03). The optimal ultrasound cut-offs for probable sarcopenia were 1.51 cm for muscle thickness (p= 0.017) and 73.95 for muscle stiffness (p = 0.004).<br />Discussion: we described muscle ultrasound characteristics in post COVID-19 patients. Muscle ultrasound could be an innovative tool to assess muscle mass and quality in this population. Our preliminary findings need to be confirmed by future studies comparing muscle ultrasound with already validated techniques for measuring muscle mass and quality.<br />Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.<br /> (Copyright © 2022 Damanti, Cilla, Tuscano, De Lorenzo, Manganaro, Merolla, Pacioni, Pomaranzi, Tiraferri, Martinenghi, Vitali, Bosi, Conte, Giustina, Tresoldi and Rovere Querini.)
- Subjects :
- Aged
Aged, 80 and over
COVID-19 diagnosis
COVID-19 mortality
COVID-19 pathology
Cross-Sectional Studies
Extremities diagnostic imaging
Extremities physiopathology
Female
Humans
Italy epidemiology
Male
Middle Aged
Muscle, Skeletal diagnostic imaging
Muscular Diseases etiology
Muscular Diseases pathology
Muscular Diseases physiopathology
Organ Size
SARS-CoV-2 physiology
Sarcopenia diagnosis
Sarcopenia epidemiology
Sarcopenia etiology
Ultrasonography
COVID-19 epidemiology
Muscle Strength physiology
Muscle, Skeletal pathology
Muscular Diseases diagnosis
Survivors statistics & numerical data
Subjects
Details
- Language :
- English
- ISSN :
- 1664-2392
- Volume :
- 13
- Database :
- MEDLINE
- Journal :
- Frontiers in endocrinology
- Publication Type :
- Academic Journal
- Accession number :
- 35250860
- Full Text :
- https://doi.org/10.3389/fendo.2022.801133